Selected research
Industry Growth & Trends
Global Pneumonia Therapeutics Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pneumonia Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pneumonia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pneumonia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pneumonia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pneumonia Therapeutics market include Novartis, Pfizer, GlaxoSmithKline, Bayer, AstraZeneca, Tetraphase Pharmaceuticals, Merck Sharp & Dohme and Biotest, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pneumonia Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pneumonia Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pneumonia Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pneumonia Therapeutics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pneumonia Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pneumonia Therapeutics Market by Company
Novartis
Pfizer
GlaxoSmithKline
Bayer
AstraZeneca
Tetraphase Pharmaceuticals
Merck Sharp & Dohme
Biotest
Pneumonia Therapeutics Segment by Type
Vaccines
Anti-Infectives
Oxygen Therapy
Pneumonia Therapeutics Segment by Application
Clinic
Hospital
Medical Center
Other
Pneumonia Therapeutics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumonia Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumonia Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumonia Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pneumonia Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Vaccines
- Anti-Infectives
- Oxygen Therapy
Applications
- Clinic
- Hospital
- Medical Center
- Other
Companies covered
- Novartis
- Pfizer
- GlaxoSmithKline
- Bayer
- AstraZeneca
- Tetraphase Pharmaceuticals
- Merck Sharp & Dohme
- Biotest
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pneumonia Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pneumonia Therapeutics Market Size by Region (2021-2032)
- 1.4.1 Global Pneumonia Therapeutics Market Size by Region (2021-2026)
- 1.4.2 Global Pneumonia Therapeutics Market Size by Region (2027-2032)
- 1.5 Key Regions Pneumonia Therapeutics Market Size (2021-2032)
- 1.5.1 North America Pneumonia Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pneumonia Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pneumonia Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pneumonia Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pneumonia Therapeutics Market Size Growth Rate (2021-2032)
2 Pneumonia Therapeutics Market by Type
- 2.1 Type Introduction
- 2.1.1 Vaccines
- 2.1.2 Anti-Infectives
- 2.1.3 Oxygen Therapy
- 2.2 Global Pneumonia Therapeutics Market Size by Type
- 2.2.1 Global Pneumonia Therapeutics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pneumonia Therapeutics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pneumonia Therapeutics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pneumonia Therapeutics Market Size by Regions
- 2.3.1 North America Pneumonia Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pneumonia Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pneumonia Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pneumonia Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pneumonia Therapeutics Market Size Breakdown by Type (2021-2026)
3 Pneumonia Therapeutics Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinic
- 3.1.2 Hospital
- 3.1.3 Medical Center
- 3.1.4 Other
- 3.2 Global Pneumonia Therapeutics Market Size by Application
- 3.2.1 Global Pneumonia Therapeutics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pneumonia Therapeutics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pneumonia Therapeutics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pneumonia Therapeutics Market Size by Regions
- 3.3.1 North America Pneumonia Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pneumonia Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pneumonia Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pneumonia Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pneumonia Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pneumonia Therapeutics Industry Trends
- 4.2 Pneumonia Therapeutics Industry Drivers
- 4.3 Pneumonia Therapeutics Industry Opportunities and Challenges
- 4.4 Pneumonia Therapeutics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pneumonia Therapeutics Revenue (2021-2026)
- 5.2 Global Pneumonia Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pneumonia Therapeutics Key Company Headquarters & Area Served
- 5.4 Global Pneumonia Therapeutics Company, Product Type & Application
- 5.5 Global Pneumonia Therapeutics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pneumonia Therapeutics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pneumonia Therapeutics Players Market Share by Revenue in 2025
- 5.6.3 2025 Pneumonia Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis Pneumonia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novartis Pneumonia Therapeutics Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer Pneumonia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Pfizer Pneumonia Therapeutics Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 GlaxoSmithKline
- 6.3.1 GlaxoSmithKline Company Information
- 6.3.2 GlaxoSmithKline Business Overview
- 6.3.3 GlaxoSmithKline Pneumonia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 GlaxoSmithKline Pneumonia Therapeutics Product Portfolio
- 6.3.5 GlaxoSmithKline Recent Developments
- 6.4 Bayer
- 6.4.1 Bayer Company Information
- 6.4.2 Bayer Business Overview
- 6.4.3 Bayer Pneumonia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bayer Pneumonia Therapeutics Product Portfolio
- 6.4.5 Bayer Recent Developments
- 6.5 AstraZeneca
- 6.5.1 AstraZeneca Company Information
- 6.5.2 AstraZeneca Business Overview
- 6.5.3 AstraZeneca Pneumonia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 AstraZeneca Pneumonia Therapeutics Product Portfolio
- 6.5.5 AstraZeneca Recent Developments
- 6.6 Tetraphase Pharmaceuticals
- 6.6.1 Tetraphase Pharmaceuticals Company Information
- 6.6.2 Tetraphase Pharmaceuticals Business Overview
- 6.6.3 Tetraphase Pharmaceuticals Pneumonia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Tetraphase Pharmaceuticals Pneumonia Therapeutics Product Portfolio
- 6.6.5 Tetraphase Pharmaceuticals Recent Developments
- 6.7 Merck Sharp & Dohme
- 6.7.1 Merck Sharp & Dohme Company Information
- 6.7.2 Merck Sharp & Dohme Business Overview
- 6.7.3 Merck Sharp & Dohme Pneumonia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Merck Sharp & Dohme Pneumonia Therapeutics Product Portfolio
- 6.7.5 Merck Sharp & Dohme Recent Developments
- 6.8 Biotest
- 6.8.1 Biotest Company Information
- 6.8.2 Biotest Business Overview
- 6.8.3 Biotest Pneumonia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Biotest Pneumonia Therapeutics Product Portfolio
- 6.8.5 Biotest Recent Developments
7 North America
- 7.1 North America Pneumonia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pneumonia Therapeutics Market Size by Country (2021-2026)
- 7.3 North America Pneumonia Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pneumonia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pneumonia Therapeutics Market Size by Country (2021-2026)
- 8.3 Europe Pneumonia Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pneumonia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pneumonia Therapeutics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pneumonia Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pneumonia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pneumonia Therapeutics Market Size by Country (2021-2026)
- 10.3 South America Pneumonia Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pneumonia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pneumonia Therapeutics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pneumonia Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst